MYDA Advisors’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-100,000
| Closed | -$137K | – | 122 |
|
|
2024
Q2 | $137K | Sell |
100,000
-80,000
| -44% | -$110K | 0.03% | 87 |
|
|
2024
Q1 | $619K | Sell |
180,000
-40,000
| -18% | -$138K | 0.18% | 69 |
|
|
2023
Q4 | $541K | Buy |
220,000
+180,000
| +450% | +$443K | 0.18% | 51 |
|
|
2023
Q3 | $68K | Sell |
40,000
-20,000
| -33% | -$34K | 0.02% | 85 |
|
|
2023
Q2 | $180K | Buy |
60,000
+5,000
| +9% | +$15K | 0.05% | 84 |
|
|
2023
Q1 | $147K | Buy |
+55,000
| New | +$147K | 0.06% | 86 |
|
|
2022
Q3 | – | Sell |
-74,000
| Closed | -$211K | – | 142 |
|
|
2022
Q2 | $211K | Buy |
74,000
+14,000
| +23% | +$39.9K | 0.06% | 133 |
|
|
2022
Q1 | $300K | Buy |
+60,000
| New | +$300K | 0.12% | 136 |
|